Dawei Xu
Impact in
- Physiology top 0.5%
- Telomeres, Telomerase, and Senescence
- Oncology top 5%
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
Papers in
- Physiology 62
- Telomeres, Telomerase, and Senescence 61
- Oncology 19
- Drug Transport and Resistance Mechanisms 7
- Co-authors
- Magnus Björkholm (64 shared papers)Astrid Gruber (28 shared papers)Xiaotian Yuan (27 shared papers)Catharina Larsson (16 shared papers)Mi Hou (10 shared papers)Pavel Pisa (9 shared papers)Jihui Jia (11 shared papers)Tiantian Liu (20 shared papers)
- Journals
- Oncotarget (9 papers)Oncogene (7 papers)British Journal of Cancer (6 papers)International Journal of Cancer (5 papers)Biochemical and Biophysical Research Communications (5 papers)
- Partner nations
- SwedenChinaUnited States
In The Last Decade
Dawei Xu
143 papers receiving 6.2k citations
Dawei Xu's Hit Papers
Peers
Comparison fields: 5 of 100
- Physiology 2.2k
- Oncology 818
- Cancer Research 423
- Endocrinology, Diabetes and Metabolism 432
- Molecular Biology 1.4k
Countries citing papers authored by Dawei Xu
This map shows the geographic impact of Dawei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawei Xu more than expected).
Fields of papers citing papers by Dawei Xu
This network shows the impact of papers produced by Dawei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawei Xu. The network helps show where Dawei Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Dawei Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 145 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players Hit paper breakdown → | 2019 | 334 |
| 2 | 2001 | 256 | |
| 3 | 2012 | 241 | |
| 4 | 2000 | 217 | |
| 5 | 2013 | 215 | |
| 6 | 2001 | 150 | |
| 7 | 2009 | 146 | |
| 8 | 2013 | 139 | |
| 9 | Frequent amplification of the telomerase reverse transcriptase gene in human tumors. | 2000 | 129 |
| 10 | 2008 | 124 | |
| 11 | 2016 | 120 | |
| 12 | 2017 | 120 | |
| 13 | 2009 | 113 | |
| 14 | 2002 | 105 | |
| 15 | 2003 | 102 | |
| 16 | 2009 | 102 | |
| 17 | 2014 | 100 | |
| 18 | 1998 | 96 | |
| 19 | 2007 | 91 | |
| 20 | 2000 | 90 |
About Dawei Xu
Dawei Xu is a scholar working on Physiology, Oncology, Endocrinology, Diabetes and Metabolism, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 145 papers that have together received 6.3k indexed citations. Recurring topics across this work include Telomeres, Telomerase, and Senescence (61 papers), Epigenetics and DNA Methylation (18 papers), Thyroid Cancer Diagnosis and Treatment (12 papers), Bladder and Urothelial Cancer Treatments (10 papers), Inflammatory mediators and NSAID effects (7 papers), Drug Transport and Resistance Mechanisms (7 papers), Renal cell carcinoma treatment (7 papers) and Prostate Cancer Treatment and Research (5 papers). The work is most often cited by research in Physiology (2.2k citations), Oncology (818 citations), Cancer Research (423 citations), Endocrinology, Diabetes and Metabolism (432 citations) and Molecular Biology (1.4k citations). Dawei Xu has collaborated with scholars based in Sweden, China and United States. Frequent co-authors include Magnus Björkholm, Astrid Gruber, Xiaotian Yuan, Catharina Larsson, Mi Hou, Pavel Pisa, Jihui Jia, Tiantian Liu, Chengyun Zheng and Feng Kong. Their work appears in journals such as Oncotarget, Oncogene, British Journal of Cancer, International Journal of Cancer and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.